Proceedings of the American Thoracic Society Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wedzicha, J. A.
Right arrow Articles by Wilkinson, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wedzicha, J. A.
Right arrow Articles by Wilkinson, T.
The Proceedings of the American Thoracic Society 3:218-221 (2006)
© 2006 The American Thoracic Society

Impact of Chronic Obstructive Pulmonary Disease Exacerbations on Patients and Payers

Jadwiga A. Wedzicha and Tom Wilkinson

Academic Unit of Respiratory Medicine, University College, London, United Kingdom

Correspondence and requests for reprints should be addressed to Jadwiga A. Wedzicha, M.D., Academic Unit of Respiratory Medicine, Royal Free and University College Medical School, Rowland Hill Street, Hampstead, London NW3 2PF, UK. E-mail: j.a.wedzicha{at}medsch.ucl.ac.uk

ABSTRACT

Chronic obstructive pulmonary disease (COPD) is not only an established major cause of mortality and morbidity but is increasing in worldwide prevalence despite current medical interventions. The natural history of COPD is punctuated by periods of acute symptomatic, physiologic, and functional deterioration or exacerbations. These events are responsible for considerable additional morbidity and mortality and impact on patients' long-term health status. Despite advances in understanding disease mechanisms and in treatment, exacerbations continue to be the major cause of COPD-associated hospitalization, and provision for their management incurs considerable health care costs. Although pharmacologic therapies may improve clinical outcomes, these benefits must be optimized by prompt diagnosis and delivery. This will require improved understanding of this complex disease by physicians and patients alike.

Key Words: chronic obstructive pulmonary disease • clinical outcomes • exacerbations




This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Punturieri, T. L. Croxton, G. G. Weinmann, and J. P. Kiley
Chronic Obstructive Pulmonary Disease: A View from the NHLBI
Am. J. Respir. Crit. Care Med., September 1, 2008; 178(5): 441 - 443.
[Full Text] [PDF]


Home page
Eur Respir JHome page
M. G. Foreman, D. L. DeMeo, C. P. Hersh, J. J. Reilly, and E. K. Silverman
Clinical determinants of exacerbations in severe, early-onset COPD
Eur. Respir. J., December 1, 2007; 30(6): 1124 - 1130.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the American Thoracic Society.